Robert W. Fairbairn, Director at BlackRock ESG Capital Allocation Trust (ECAT), bought 25,000 shares at $17.06 ($427K) on 2022-01-26, disclosed to the SEC on 2022-01-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.06 | 12,500 | $213K | 50.0% |
| 2 | $17.06 | 12,500 | $213K | 50.0% |
| Total | $17.06 avg | 25,000 | $427K | 100% |
| Filing → |
| BMEZ | SELL | 2025-12-22 | $308K | — | Filing → |
| BTX | SELL | 2025-12-22 | $286K | — | Filing → |
| ECAT | BUY | 2022-05-13 | $1.2M | — | Filing → |